CIMINO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 7.106
EU - Europa 2.139
AS - Asia 866
SA - Sud America 43
AF - Africa 33
OC - Oceania 3
Totale 10.190
Nazione #
US - Stati Uniti d'America 7.018
IT - Italia 721
SE - Svezia 456
IN - India 437
CN - Cina 293
UA - Ucraina 245
FI - Finlandia 224
DE - Germania 115
SG - Singapore 98
CA - Canada 85
GB - Regno Unito 78
RO - Romania 74
BG - Bulgaria 61
BE - Belgio 46
AR - Argentina 37
IE - Irlanda 36
TG - Togo 24
FR - Francia 23
GR - Grecia 18
NL - Olanda 16
IR - Iran 14
CH - Svizzera 11
HK - Hong Kong 8
JP - Giappone 5
TR - Turchia 5
ZA - Sudafrica 5
BR - Brasile 3
CL - Cile 3
MX - Messico 3
PT - Portogallo 3
AU - Australia 2
DK - Danimarca 2
ES - Italia 2
PL - Polonia 2
RU - Federazione Russa 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HU - Ungheria 1
KR - Corea 1
MN - Mongolia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
Totale 10.190
Città #
Fairfield 1.201
Woodbridge 568
Chandler 557
Ashburn 506
Houston 435
Seattle 424
Wilmington 389
Cambridge 381
Ann Arbor 290
Princeton 272
Rome 233
Plano 216
San Paolo di Civitate 216
Beijing 201
Lawrence 137
Boston 133
San Diego 93
Millbury 92
Jacksonville 86
Des Moines 83
Dearborn 72
Sofia 61
Andover 59
Norwalk 50
Brussels 46
Singapore 43
Ottawa 41
Toronto 39
Dublin 36
Federal 36
Southend 34
Bremen 33
Boardman 32
Helsinki 27
New York 26
Lomé 24
Falls Church 23
San Mateo 22
Trento 17
Milan 16
Hefei 15
Nanjing 14
Bühl 13
Kunming 12
Bologna 10
Redmond 10
Buffalo 9
Paris 9
Pune 9
Fremont 8
Hong Kong 8
Indiana 8
Simi Valley 8
London 7
Los Angeles 7
Provo 6
Zurich 6
Bern 5
Nanchang 5
Phoenix 5
Amsterdam 4
Catania 4
Cosenza 4
Genoa 4
Guangzhou 4
Izmir 4
Jinan 4
Laurel 4
Leawood 4
Muizenberg 4
Tappahannock 4
Tehran 4
Auburn Hills 3
Capoterra 3
Casoria 3
Fasano 3
Fiano Romano 3
Frosinone 3
Greifswald 3
Hyderabad 3
Montréal 3
Naples 3
Pavia 3
San Jose 3
San Remo 3
Shanghai 3
Wuhan 3
Zanjan 3
Alcamo 2
Cagliari 2
Changsha 2
Eindhoven 2
Frascati 2
Genzano Di Roma 2
Kilburn 2
Marseille 2
Mcallen 2
Meppel 2
Mexico City 2
Mountain View 2
Totale 7.544
Nome #
EuPRAXIA@SPARC_LAB Design study towards a compact FEL facility at LNF 125
Assembly and functional analysis of an S/MAR based episome with the cystic fibrosis transmembrane conductance regulator gene 97
The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. 96
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients 95
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 90
SUSTAINED MOLECULAR REMISSION AFTER LOW DOSE GEMTUZUMAB-OZOGAMICIN IN ELDERLY PATIENTS WITH ADVANCED ACUTE PROMYELOCYTIC LEUKEMIA 87
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 86
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study. 84
Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: Results of a crossover, randomized clinical trial 84
Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine 83
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease 82
Reactive-Oxygen-Species-Mediated P. aeruginosa Killing Is Functional in Human Cystic Fibrosis Macrophages 81
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 80
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen 80
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy 79
Tapentadol prolonged release for patients with multiple myeloma suffering from moderate-to-severe cancer pain due to bone disease 78
A case of Burkitt lymphoma-L3 ALL with t(8;14)translocation, developed 10 years after Hodgkin's disease. 78
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression 75
GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors 74
Evaluation of therapeutic modalities in the control of Hodgkin's disease. 74
ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia 74
HDAC inhibition by valproic acid decreases JAK2V617F levels in myeloproliferative neoplasms via up-regulation of miR-101, in vivo and in vitro 74
Genetic lesions disrupting calreticulin 3′-untranslated region in JAK2 mutation-negative polycythemia vera 74
BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. 72
Haemolytic uremic syndrome during induction therapy in an acute promyelocytic leukemia patient with aberrant phenotype: a possible manifestation of retinoic acid syndrome. 72
Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming 71
Chemotherapy alone for the treatment of early-stage Hodgkin's disease. 71
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia 70
The role of restaging laparotomy in Hodgkin's disease. 70
Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells 70
An acute promyelocytic leukaemia patient with a new atypical promyelocytic leukemia breakpoint 68
Current trends in management of hepatitis B virus reactivation in the biologic therapy era 68
A sustained CD16 aggregation induced by therapeutic antibody-opsonised targets impairs cytotoxic responses in human NK cells 68
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 67
Solitary plasmacytoma of tibia: A possible correlation with younger age 67
Comparison of 18F FDG PET-CT AND CECT in pretreatment staging of adults with Hodgkin's lymphoma 66
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 65
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. 64
Acute leukaemia in patients treated for Hodgkin's disease 64
Analysis of the BCL-6 gene configuration in diffuse B-cell non-Hodgkin's lymphomas and Hodgkin's disease. 64
Late relapses in acute promyelocytic leukaemia 64
Sequential Valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia. 64
Adult patients affected by cystic fibrosis in therapy with cystic fibrosis transmembrane regulator modulators and lung transplant: renal function, metabolic and nutritional status 64
Comorbidities and FLT3-ITD Abnormalities as Independent Prognostic Indicators of Survival in Elderly Acute Myeloid Leukaemia Patients 63
A complete remission induced by valproic acid in a patient with essential thrombocytemia JAKV617F- positive 63
Thrombosis and survival in essential thrombocythemia: A regional study of 1,144 patients 63
ARTERIAL AND VENOUS THROMBOSIS IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: INCIDENCE AND RISK FACTORS IN A COHORT OF 1,491 PATIENTS 63
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene 62
Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements. 62
MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. 62
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment 62
Trisomy 13 in a patient with common acute lymphoblastic leukemia. Description of a case and review of the literature. 61
Umbilical cord blood transplant from unrelated HLA-mismatched donors in children with high risk leukemia 61
Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients 61
Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid 61
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols 60
Secondary acute non lymphoid leukemia in patients treated for non Hodgkin's lymphoma: No risk of therapy-related ANLL after PROVECIP schedule 60
Intracardiac thrombus in a patient with autoimmune hemolytic anemia leading to a diagnosis of antiphospholipid syndrome. 60
High serum interleukin-2 levels in acute myeloid leukaemia (AML) are associated with FAB M4 and M5 subtypes. 59
High serum IL-2 levels are predictive of prolonged survival in multiple myeloma 59
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms 59
Prognostic Factors Associated With Progression of Smoldering Multiple Myeloma to Symptomatic Form 59
Differential Toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection 59
Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin 59
Negative impact of FLT3 abnormalities in elderly acute myeloid leukemia patients 57
Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features 57
Role of NFIB in normal hematopoiesis and MyeloproliferativeNeoplasms 57
Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms 57
The t(4;11) chromosome translocation of human acute leukemias fuses the ALL1 gene, related to drosophila trithorax, to the AF4 gene 56
A multiplex reverse transcription-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia. 56
Survival after lung transplant for cystic fibrosis in italy. A single center experience with 20 years of follow-up 56
THE (4 11)(Q21 Q23) CHROMOSOME TRANSLOCATIONS IN ACUTE LEUKEMIAS INVOLVE THE VDJ RECOMBINASE 56
Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum 55
MOPP CHEMOTHERAPY VERSUS EXTENDED-FIELD RADIOTHERAPY IN THE MANAGEMENT OF PATHOLOGICAL STAGES I-IIA HODGKINS-DISEASE 55
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian Study Group report 55
Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia 55
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies 55
Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia 55
null 54
FLT3 positive acute myeloid leukemia: A single center experience 54
Sequential combination chemotherapy of high-grade non-Hodgkin's lymphoma with 5-fluorouracil, methotrexate, cytosine-arabinoside, cyclophosphamide, doxorubicin, vincristine, and prednisone (F-MACHOP) 54
Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatement in patients enrolled in the GIMEMA LAL 0496 protocol. 53
Are ET and PV Patients Two Similar Populations As Concern Thrombotic Risk Factors? 53
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leucemia. 53
A novel germline mutation in the 3'Untranslated region of Calreticulin gene induces JAK/STAT signaling activation and Erythrocytosis. 53
Effects of hydration with salt repletion on renal toxicity of conventional amphotericin B empirical therapy: a prospective study in patients with hematological malignancies 53
Risk Factors for Thrombosis Vary According to Age in Patients with Essential Thrombocythemia: a Retrospective Analysis of 1090 Patients from the "Gruppo Laziale SMPC Ph Negative 51
A population-based study on myelodysplastic syndromes in the Lazio Region (Italy), medical miscoding and 11-year mortality follow-up. The Gruppo Romano-Laziale Mielodisplasie experience of retrospective multicentric registry 51
Hodgkin lymphoma in pregnancy. Good news for clinicians and women 51
A novel germline CALR mutation affecting an evolutionary conserved region of 3’UTR in JAK2-negative siblings with Polycythemia Vera 51
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit 50
A Genotypic-oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macro-categories of Cystic Fibrosis. 50
null 50
Thrombosis History and Relationship with Low Thrombocytosis, Leukocytosis, and Jak2 V617F Mutation In A Cohort of 977 Patients with Essential Thrombocythemia (ET): Preliminary Report of the Registro Italiano Trombocitemia(RIT) 49
null 49
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis. 49
Increased IL-8 production in human CFTR-deficient macrophages 49
Second primary cancer following Hodgkin's disease: Updated results of an Italian multicentric study 47
Multiple thromboembolism with multiple causes in a 69-year-old woman: A case report 47
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report 47
Totale 6.457
Categoria #
all - tutte 27.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019718 0 0 0 0 0 0 0 0 0 0 409 309
2019/20202.459 373 72 34 106 253 297 301 286 257 244 152 84
2020/2021902 108 99 30 83 39 38 39 106 115 134 85 26
2021/20222.340 19 127 198 148 313 70 44 217 178 201 322 503
2022/20232.268 482 533 86 228 183 297 36 131 186 18 65 23
2023/2024750 76 148 35 63 92 112 36 48 9 127 4 0
Totale 10.490